Cargando…

Quantitative Trait Loci Associated with Promoting Effects of Sodium l‐Ascorbate on Two‐stage Bladder Carcinogenesis in Rats

In the two‐stage rat bladder carcinogenesis model using N‐butyl‐N‐(4‐hydroxybutyl)nitrosamine (BBN) as an initiator and sodium l‐ascorbate (SA) as a promoter, we found a notable strain difference between F344/DuCrj (F344) and WS/Shi (WS) rats in susceptibility to the promoting effect of SA. Twenty e...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamoto, Toshiyuki, Mori, Satoru, Murai, Takashi, Yamada, Yoshihiro, Makino, Susumu, Yoshida, Osamu, Hiai, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 1997
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921485/
https://www.ncbi.nlm.nih.gov/pubmed/9310135
http://dx.doi.org/10.1111/j.1349-7006.1997.tb00430.x
Descripción
Sumario:In the two‐stage rat bladder carcinogenesis model using N‐butyl‐N‐(4‐hydroxybutyl)nitrosamine (BBN) as an initiator and sodium l‐ascorbate (SA) as a promoter, we found a notable strain difference between F344/DuCrj (F344) and WS/Shi (WS) rats in susceptibility to the promoting effect of SA. Twenty each of F344, WS and reciprocal F(1) hybrid rats were given 0.05% BBN in their drinking water for 4 weeks and then a basal diet with (BBN‐SA group) or without (BBN group) a 5% SA supplement for 32 weeks. In F344 and also in reciprocal F(1) hybrids, the number of tumors per rat was significantly higher in the BBN‐SA group than in the BBN group (P<0.0001). In contrast, WS rats were not significantly affected by either treatment (P=0.8). These findings indicate that F344 rats are highly susceptible to the promoter effect of SA, but WS rats are not. Linkage analysis of 108 WS X (WSXF344) F(1) backcrosses revealed that this difference was related to a quantitative trait locus mapped on rat Chr. 17 (maximum LOD score, 3.86) named Bladder Tumor Susceptible‐I and possibly another locus on Chr. 5 (maximum LOD score, 2.39). This study has provided the first evidence that host genes influence the risk of bladder cancer development.